Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.58 $5.85 Wednesday, 8th May 2024 CTMX stock ended at $4.19. This is 2.95% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.95% from a day low at $3.79 to a day high of $4.21.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jan 23, 2023 $2.57 $2.80 $2.49 $2.73 3 304 190
Jan 20, 2023 $2.50 $2.54 $2.45 $2.52 2 530 391
Jan 19, 2023 $2.55 $2.59 $2.46 $2.50 2 015 748
Jan 18, 2023 $2.69 $2.76 $2.50 $2.53 2 086 400
Jan 17, 2023 $2.86 $2.86 $2.62 $2.67 1 827 806
Jan 13, 2023 $2.73 $2.92 $2.71 $2.86 2 625 205
Jan 12, 2023 $2.75 $2.88 $2.61 $2.73 3 648 900
Jan 11, 2023 $2.74 $2.84 $2.63 $2.74 2 703 846
Jan 10, 2023 $2.82 $2.95 $2.67 $2.78 4 822 900
Jan 09, 2023 $2.46 $3.02 $2.45 $2.88 12 413 700
Jan 06, 2023 $2.96 $2.98 $2.34 $2.52 51 298 900
Jan 05, 2023 $1.70 $1.88 $1.67 $1.79 7 181 285
Jan 04, 2023 $1.61 $1.69 $1.59 $1.67 1 602 239
Jan 03, 2023 $1.62 $1.68 $1.57 $1.61 889 395
Dec 30, 2022 $1.55 $1.61 $1.50 $1.60 771 744
Dec 29, 2022 $1.55 $1.61 $1.50 $1.57 578 905
Dec 28, 2022 $1.47 $1.54 $1.46 $1.54 814 136
Dec 27, 2022 $1.52 $1.55 $1.43 $1.45 625 556
Dec 23, 2022 $1.57 $1.57 $1.51 $1.55 404 966
Dec 22, 2022 $1.49 $1.55 $1.46 $1.53 320 459
Dec 21, 2022 $1.52 $1.56 $1.50 $1.51 475 508
Dec 20, 2022 $1.51 $1.52 $1.45 $1.50 575 442
Dec 19, 2022 $1.57 $1.58 $1.49 $1.53 948 551
Dec 16, 2022 $1.59 $1.62 $1.55 $1.57 1 307 923
Dec 15, 2022 $1.61 $1.64 $1.59 $1.59 303 016
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT